Key facts
- Nvidia plans to buy stakes in French tech startups Doctolib, Genesis AI, Pigment, and Entalpic.
US chipmaker Nvidia plans to buy stakes in four French technology startups: Doctolib, Genesis AI, Pigment, and Entalpic. The investments aim to support the development of artificial intelligence tools and expand Nvidia's commitments in France across various sectors.

The investments signal Nvidia's continued strategic expansion into key European technology hubs, particularly in AI-driven sectors like healthcare, robotics, and enterprise software, potentially influencing the competitive landscape and innovation pace in these fields.
US chipmaker Nvidia has agreed to buy stakes in four French technology startups: Doctolib, Genesis AI, Pigment, and Entalpic, according to reports from Les Echos and Reuters. The investments, announced on October 13, 2026, aim to bolster Nvidia's presence in France and support advancements in artificial intelligence across various sectors.
Doctolib, a European healthcare technology company, previously stated that Nvidia's investment would help it develop AI tools, though specific stake sizes and values were not disclosed. Genesis AI is a global robotics company focused on developing general-purpose robots. Pigment is an enterprise software company that provides a platform for business planning and decision-making. Entalpic, based in Paris, specializes in accelerating the engineering of advanced materials at the atomic scale.
Nvidia has committed nearly $10 billion to the technology ecosystem across Europe, though specific figures for France were not detailed. The company has also previously invested in other French technology firms such as Alice&Bob, Gradium, and Scintil Photonics. The announcement also highlighted Nvidia's infrastructure and deployment activities within France's AI ecosystem, including collaborations on sovereign AI platforms and advanced modeling.
Pick the topics you care about. Get only what matters, on your cadence.